Posters, Scientific Publications

Evaluation of a new co-cultured microbiome ecosystem therapy candidate (MaaT034) for clinical testing as adjuvant/neoadjuvant to immune checkpoint inhibitors in solid tumors

Date : March 19, 2024

Download the poster

March 19, 2024: MaaT Pharma To Present New Preclinical Data at AACR for MaaT034 Aiming To Improve Patients’ Responses to Immunotherapies

March 21, 2024: MaaT Pharma Strengthens Executive Team Appointing Jonathan Chriqui as Chief Business Officer